- Home
- CLAR vs IPHA Comparison
CLAR vs IPHA Comparison
Compare CLAR & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLAR
- IPHA
- Stock Information
- Founded
- CLAR 1957
- IPHA 1999
- Country
- CLAR United States
- IPHA France
- Employees
- CLAR N/A
- IPHA N/A
- Industry
- CLAR Recreational Games/Products/Toys
- IPHA Biotechnology: Pharmaceutical Preparations
- Sector
- CLAR Consumer Discretionary
- IPHA Health Care
- Exchange
- CLAR Nasdaq
- IPHA Nasdaq
- Market Cap
- CLAR 173.0M
- IPHA 148.3M
- IPO Year
- CLAR N/A
- IPHA 2019
- Fundamental
- Price
- CLAR $4.78
- IPHA $1.77
- Analyst Decision
- CLAR Strong Buy
- IPHA Strong Buy
- Analyst Count
- CLAR 3
- IPHA 1
- Target Price
- CLAR $6.33
- IPHA $11.50
- AVG Volume (30 Days)
- CLAR 162.3K
- IPHA 42.3K
- Earning Date
- CLAR 03-06-2025
- IPHA 09-12-2024
- Dividend Yield
- CLAR 2.10%
- IPHA N/A
- EPS Growth
- CLAR N/A
- IPHA N/A
- EPS
- CLAR 0.13
- IPHA N/A
- Revenue
- CLAR $269,413,000.00
- IPHA $36,202,722.00
- Revenue This Year
- CLAR N/A
- IPHA N/A
- Revenue Next Year
- CLAR $9.30
- IPHA $101.65
- P/E Ratio
- CLAR $37.66
- IPHA N/A
- Revenue Growth
- CLAR 48.98
- IPHA N/A
- 52 Week Low
- CLAR $3.89
- IPHA $1.29
- 52 Week High
- CLAR $7.55
- IPHA $3.51
- Technical
- Relative Strength Index (RSI)
- CLAR 56.15
- IPHA 46.55
- Support Level
- CLAR $4.30
- IPHA $1.65
- Resistance Level
- CLAR $4.65
- IPHA $1.87
- Average True Range (ATR)
- CLAR 0.15
- IPHA 0.12
- MACD
- CLAR 0.02
- IPHA -0.03
- Stochastic Oscillator
- CLAR 82.29
- IPHA 33.47
About CLAR Clarus Corporation
Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a global leader in designing, manufacturing, and marketing innovative outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of highly-engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.